about
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsStudy of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic HyponatremiaA Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic HyponatremiaPharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult SubjectsComparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusComparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusSurgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenSurveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenA Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinOral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
P859
Q61906826-62B60403-7528-4F49-8A6A-018CBB492B66Q61917917-07BC1804-2D5D-4D11-90CB-CE04DB810E87Q61967258-421FF0E5-3747-4906-8028-ED87D47D08C7Q61980857-00D980C5-04D9-41F7-B33F-80C3DE0B4561Q62105568-B3EF99F4-37C8-4319-A656-CDF4C46C4F16Q62105570-327AF16F-0A36-40D6-BC86-60FEA38DF1A6Q63336320-5EA367D4-550A-4FFE-9C93-68867A914476Q63336324-6934F35D-62A2-4298-92ED-3B465B993038Q63340448-60E199C8-D3F7-4A08-A1D8-86730CBA1D7BQ63812224-921491F6-64B6-4780-8908-1C95339F2685
P859
description
Company in Nashville Tennessee United States
@en
americká firma
@cs
name
Cumberland Pharmaceuticals (United States)
@en
Cumberland Pharmaceuticals
@fr
type
label
Cumberland Pharmaceuticals (United States)
@en
Cumberland Pharmaceuticals
@fr
prefLabel
Cumberland Pharmaceuticals (United States)
@en
Cumberland Pharmaceuticals
@fr
P3153
P159
P213
0000 0004 0491 2533
P2427
grid.421699.1